Utah Medical Products Inc (UTMD)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $204.92M
Last updated: Nov 17, 2026 at 11:05 AM ET
Utah Medical Products Inc (UTMD) P/E Ratio & Valuation History
Utah Medical Products (UTMD) trades at 21.7x trailing earnings and 6.6x sales. Its P/E of 21.7x is above its 5-year median of 18.5x. Its forward P/E is 13.0x. The median P/E across 6 similar companies is 21.9x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 66.9% higher over the next year. Its free cash flow yield is 4.7%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 21.7x |
| Forward P/E | 13.0x |
| Price to sales | 6.6x |
| Price to book | 1.9x |
| EV/EBITDA | 12.0x |
| Price to FCF | 21.2x |
| EV/FCF | 13.4x |
| PEG | 4.3 |
| FCF yield | 4.7% |
Historical Medians
Against its 10-year medians, its P/E is 8.0% above 20.1x, its P/S is in line and its P/B is 36.7% below 3.0x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 21.7x | 18.5x | 20.1x |
| P/S | 6.6x | 5.8x | 6.6x |
| P/B | 1.9x | 2.0x | 3.0x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 15.6x in 2024 to 28.0x in 2019.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $55.96 | 16.1x | 4.7x | 1.5x |
| 2024 | $61.47 | 15.6x | 5.3x | 1.8x |
| 2023 | $84.22 | 18.4x | 6.1x | 2.4x |
| 2022 | $100.53 | 22.3x | 7.0x | 3.2x |
| 2021 | $100.00 | 24.7x | 7.4x | 3.4x |
| 2020 | $84.30 | 15.8x | 7.3x | 3.0x |
| 2019 | $107.90 | 28.0x | 8.6x | 4.0x |
| 2018 | $83.08 | 20.4x | 7.4x | 3.5x |
| 2017 | $81.40 | 20.8x | 7.3x | 3.9x |
| 2016 | $72.75 | 23.2x | 7.0x | 3.9x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About UTMD
What is UTMD's forward P/E ratio?
Utah Medical Products has a forward P/E ratio of 13.0x.
Is UTMD stock overvalued?
GNG's valuation label for UTMD is Fairly valued. Its P/E of 21.7x compares with a median of 21.9x across 6 similar companies.
What is UTMD's price to sales ratio?
Utah Medical Products has a price to sales ratio of 6.6x.
What is Utah Medical Products's average P/E ratio over 5 years?
Utah Medical Products's median P/E over the last 5 years is 18.5x, from 60 month-end values through Oct 2026.
What is UTMD's PEG ratio?
Utah Medical Products has a PEG ratio of 4.3.
UTMD pages: Overview, Dividends, Earnings, Financials, Valuation, Competitors